InvestorsHub Logo
icon url

runninggirl2016

02/04/18 2:20 PM

#215776 RE: DaubersUP #215771

Daubers I'm with you.
A couple BILLION up front for B and 50/50 sales on ALL current and future indications. 1 Pharma 1 MEGA deal.
3 B drugs heading in to phase3 in BILLION dollar indications warrants a HUGE up front payment.
icon url

tryz

02/04/18 3:43 PM

#215785 RE: DaubersUP #215771

Wouldn't it make sense for the 20 or so bio-pharma's that signed CDA'S with IPIX to start buying the living hell of IPIX shares knowing that there is a winning leading novel drug or drugs to be commercialized and someone will win the negotiation prize or are they barred from buting stock shares by agreements signed?
icon url

wsbc

02/05/18 11:15 AM

#215846 RE: DaubersUP #215771

Agreed... one partner would be the launch-pad to bring several things about. SP increase, available cash/favourable balance sheet in the revenue dept, and also would serve as a potential safety-signal for additional partners. Having a product sale would accomplish similar goals, with an individual license of a formulation for a specific indication of B; enabling them to post some revenue, drive SP, and then proceed to uplist. Once uplisted, they're on the open market for institutional investing which is the other wildcard to drive SP. Sky's sort of the limit here.